VRAX
Virax Biolabs Group Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.19
-0.01 ▼ -2.55%
🌙 3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.19
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.25 | Insider Own | 5.9% | Shs Outstand | 0.01B | Perf Week | -10.96% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | -12.06% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -0.07 | Inst Own | 11.57% | Short Float | 0.8% | Perf Quarter | -60.94% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | -9.63% | Short Ratio | 0.18 | Perf Half Y | -67.07% |
| Sales | 0.00B | P/B | 0.24 | EPS next 5Y | 57.19% | ROA | -74.46% | Short Interest | 0.06M | Perf YTD | -44.77% |
| Book/sh | 0.81 | P/C | 0.42 | EPS past 3/5Y | -2.65% -21.07% | ROE | -80.87% | 52W High | -87.91% ($1.58) | Perf Year | -85.19% |
| Cash/sh | 0.45 | P/FCF | - | Sales past 3/5Y | - -42.4% | ROIC | -100.99% | 52W Low | 0.9% ($0.19) | Perf 3Y | -97.67% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 47.25% | Gross Margin | -14976.66% | Volatility(W/M) | 9.23% 10.61% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -96.48% | Oper. Margin | -196566.68% | ATR (14) | 0.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 11.21 | EPS Q/Q | 44.72% | Profit Margin | -189001.71% | RSI (14) | 36.01 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 11.35 | Sales Q/Q | -67.53% | SMA20 | -9.48% ($0.21) | Beta | 1.72 | Target Price | $1 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 2025/12/03 | SMA50 | -27.26% ($0.26) | Rel Volume | 0.28 | Prev Close | $0.2 |
| Employees | 19 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | - | SMA200 | -66.68% ($0.57) | Avg Volume(3M) | 0.30M | Price | $0.19 |
| IPO | 2022/7/21 | Option/Short | No/Yes | Trades | 150 | Volume | 84,932 | Change | -2.55% |
뉴스 로딩 중...